Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Douglas Lauffenburger and Galit Alter.
Douglas Lauffenburger
Connection Strength
3.234
Galit Alter
  1. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun. 2021 02 15; 12(1):1018.
    View in: PubMed
    Score: 0.232
  2. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021 03; 27(3):454-462.
    View in: PubMed
    Score: 0.232
  3. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021 02 04; 184(3):628-642.e10.
    View in: PubMed
    Score: 0.230
  4. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 2020 12 10; 183(6):1508-1519.e12.
    View in: PubMed
    Score: 0.228
  5. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity. mSphere. 2020 09 02; 5(5).
    View in: PubMed
    Score: 0.225
  6. SARS-CoV-2-specific ELISA development. J Immunol Methods. 2020 Sep - Oct; 484-485:112832.
    View in: PubMed
    Score: 0.224
  7. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. Immunity. 2020 09 15; 53(3):524-532.e4.
    View in: PubMed
    Score: 0.224
  8. Publisher Correction: IFN-?-independent immune markers of Mycobacterium tuberculosis exposure. Nat Med. 2019 Jul; 25(7):1175.
    View in: PubMed
    Score: 0.208
  9. IFN-?-independent immune markers of Mycobacterium tuberculosis exposure. Nat Med. 2019 06; 25(6):977-987.
    View in: PubMed
    Score: 0.206
  10. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Sci Immunol. 2018 08 17; 3(26).
    View in: PubMed
    Score: 0.195
  11. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host Microbe. 2018 08 08; 24(2):221-233.e5.
    View in: PubMed
    Score: 0.195
  12. Exploiting glycan topography for computational design of Env glycoprotein antigenicity. PLoS Comput Biol. 2018 04; 14(4):e1006093.
    View in: PubMed
    Score: 0.191
  13. Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors. AIDS. 2018 02 20; 32(4):443-450.
    View in: PubMed
    Score: 0.189
  14. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
    View in: PubMed
    Score: 0.059
  15. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2. JCI Insight. 2021 03 22; 6(6).
    View in: PubMed
    Score: 0.058
  16. Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2021 Feb; 590(7844):E25.
    View in: PubMed
    Score: 0.058
  17. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021 02; 590(7847):630-634.
    View in: PubMed
    Score: 0.057
  18. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell. 2020 12 10; 183(6):1496-1507.e16.
    View in: PubMed
    Score: 0.057
  19. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 11; 26(11):1694-1700.
    View in: PubMed
    Score: 0.056
  20. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 10; 586(7830):583-588.
    View in: PubMed
    Score: 0.056
  21. Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir. JCI Insight. 2019 09 05; 4(17).
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.